サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：局所薬剤送達の世界市場 (～2027年)：製品・投与経路・エンドユーザー・流通チャネル・地域別の競合分析・市場予測・成長機会
市場調査レポート
商品コード
1101535

局所薬剤送達の世界市場 (～2027年)：製品・投与経路・エンドユーザー・流通チャネル・地域別の競合分析・市場予測・成長機会

Global Topical Drug Delivery Market, By Product By Route of Administration By End-User By Distribution Channel By Region, Competition Forecast & Opportunities, 2027
出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

局所薬剤送達の世界市場 (～2027年)：製品・投与経路・エンドユーザー・流通チャネル・地域別の競合分析・市場予測・成長機会
出版日: 2022年07月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の局所薬剤送達の市場は予測期間中、安定したCAGRで成長すると予想されています。

火傷の事例の世界的な増加や経皮薬剤送達システムの進歩などの要因が同市場の需要を促進しています。また、費用対効果や患者の治癒が早いことから、非侵襲的な処置が好まれており、今後5年間の市場成長にさらに影響を及ぼすと予想されています。

製品別で見ると、半固形製剤の部門が市場をリードしており、予測期間中もその位置付けを維持すると予測されています。外科手術や臓器移植の増加が同部門の需要を促進しています。

当レポートでは、世界の局所薬剤送達の市場を調査し、市場概要、市場規模の推移・予測、各種区分・地域/主要国別の内訳、市場への各種影響因子の分析、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の局所薬剤送達市場に対するCOVID-19の影響

第5章 顧客の声

第6章 世界の局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別 (半固体製剤・液体製剤・固体製剤・経皮製品)
    • 投与経路別 (経皮・眼科・直腸・膣・経鼻)
    • エンドユーザー別 (病院・診療所・在宅ヘルスケア・診断センター・その他)
    • 流通チャネル別 (オンライン・オフライン)
    • 企業別
    • 地域別 (北米・欧州・アジア太平洋・南米・中東&アフリカ)
  • 製品市場マップ

第7章 北米の局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別
    • 投与経路別
    • エンドユーザー別
    • 流通チャネル別
    • 国別

第8章 欧州の局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別
    • 投与経路別
    • エンドユーザー別
    • 流通チャネル別
    • 国別

第9章 アジア太平洋の局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別
    • 投与経路別
    • エンドユーザー別
    • 流通チャネル別
    • 国別

第10章 中東&アフリカの局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別
    • 投与経路別
    • エンドユーザー別
    • 流通チャネル別
    • 国別

第11章 南米の局所薬剤送達市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品別
    • 投与経路別
    • エンドユーザー別
    • 流通チャネル別
    • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向・市場展開

第14章 競合情勢

  • 競合の見通し
  • 世界的企業のプロファイル (主要企業)
    • Johnson & Johnson SA
    • Nestle SA
    • GlaxoSmithKline Plc
    • Novartis AG
    • Merck & Co. Inc.
    • Crescita Therapeutics Inc.
    • Cipla Ltd.
    • Taro Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals International Inc.
    • Glenmark Pharmaceuticals Ltd.
    • Bayer AG
    • Encore Dermatology, Inc.
    • MedPharm Group Ltd.
    • Skinvisible Pharmaceuticals, Inc.
    • Galderma S.A.

第15章 戦略的推奨事項

目次
Product Code: 7362

The global topical drug delivery market is anticipated to witness a growth with a steady CAGR in the forecast period, 2023-2027. Factors such as increased incidence of burn injuries across the globe and advancements in the transdermal drug delivery systems are primarily driving the market demand. The rise at the old age population who prefer to use tropical drug delivery as it eases the drug delivery process fuels the market demand. Also, the growing popularity of the non-invasive procedures due to their cost-effectiveness and fast healing among patients is further expected to influence the market growth in the next five years.

The global topical drug delivery market is segmented into product, route of administration, end user, distribution channel, regional distribution, and competitive landscape. Based on product, the market is fragmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations dominate the market and are anticipated to maintain their dominance over the forecast period, 2023-2027. Lotions, creams, gels, pastes, ointments, and other semi-solid formulations are some examples of semi-solid formulations that are used topically. These formulations are absorbed through the skin, and the therapeutic ingredients do the same, penetrating the skin to enter the body's bloodstream through tiny capillaries. They fix any damage or abnormality in the epidermal tissues that cover the surface of the body. The rise in the number of surgeries and organ transplantation procedures is driving the segment demand.

The major market players operating in the global topical drug delivery market are Johnson & Johnson SA, Nestle SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd., Bayer AG, Encore Dermatology, Inc., MedPharm Group Ltd., Skinvisible Pharmaceuticals, Inc., and Galderma S.A.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global topical drug delivery market from 2017 to 2021.
  • To estimate and forecast the market size of global topical drug delivery market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global topical drug delivery market based on product, route of administration, end user, distribution channel, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global topical drug delivery market.
  • To identify drivers and challenges for global topical drug delivery market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global topical drug delivery market.
  • To identify and analyze the profile of leading players operating in global topical drug delivery market.
  • To identify key sustainable strategies adopted by market players in global topical drug delivery market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies, suppliers, and service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global topical drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • End users, service providers and other stakeholders
  • Distributers and suppliers of topical drugs and other stakeholders
  • Organizations, forums, and alliances related to topical drug delivery market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global Topical Drug Delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Topical Drug Delivery Market, By Product:

Semi-Solid Formulations

Liquid Formulations

Solid Formulations

Transdermal Products

  • Global Topical Drug Delivery Market, By Route of Administration:

Dermal Drug Delivery

Ophthalmic Drug Delivery

Rectal Drug Delivery

Vaginal Drug Delivery

Nasal Drug Delivery

  • Global Topical Drug Delivery Market, By Distribution Channel:

Online

Offline

  • Global Topical Drug Delivery Market, By End User:

Hospitals

Clinics

Home Healthcare

Diagnostic Centers

Others

  • Global Topical Drug Delivery Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global topical drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Topical Drug Delivery Market

5. Voice of Customer

6. Global Topical Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
    • 6.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery)
    • 6.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
    • 6.2.4. By Distribution Channel (Online vs. Offline)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
  • 6.3. Product Market Map

7. North America Topical Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By End User
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Topical Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Topical Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By End User
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Topical Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4. By Distribution Channel

8. Europe Topical Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By End User
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country (France; Germany; UK; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Topical Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By End User
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Germany Topical Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By End User
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. United Kingdom Topical Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By End User
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Italy Topical Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By End User
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Topical Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By End User
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Topical Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By End User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country (China; India; Japan; South Korea; Australia)
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Topical Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By End User
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Topical Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By End User
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Topical Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By End User
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. South Korea Topical Drug Delivery Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By End User
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. Australia Topical Drug Delivery Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By End User
        • 9.3.5.2.4. By Distribution Channel

10. Middle East and Africa Topical Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By End User
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country (UAE; Saudi Arabia; South Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Topical Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By End User
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By End User
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Topical Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By End User
        • 10.3.3.2.4. By Distribution Channel

11. South America Topical Drug Delivery Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Route of Administration
    • 11.2.3. By End User
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country (Brazil; Argentina; Colombia)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Topical Drug Delivery Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By End User
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. Argentina Topical Drug Delivery Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By End User
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. Colombia Topical Drug Delivery Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By End User
        • 11.3.3.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Global Players Profiled (Leading Companies)
    • 14.2.1. Johnson & Johnson SA
    • 14.2.2. Nestle SA
    • 14.2.3. GlaxoSmithKline Plc
    • 14.2.4. Novartis AG
    • 14.2.5. Merck & Co. Inc.
    • 14.2.6. Crescita Therapeutics Inc.
    • 14.2.7. Cipla Ltd.
    • 14.2.8. Taro Pharmaceutical Industries Ltd.
    • 14.2.9. Valeant Pharmaceuticals International Inc.
    • 14.2.10. Glenmark Pharmaceuticals Ltd.
    • 14.2.11. Bayer AG
    • 14.2.12. Encore Dermatology, Inc.
    • 14.2.13. MedPharm Group Ltd.
    • 14.2.14. Skinvisible Pharmaceuticals, Inc.
    • 14.2.15. Galderma S.A.

15. Strategic Recommendations